Ta-Ming Liu

963 total citations
3 papers, 135 citations indexed

About

Ta-Ming Liu is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Ta-Ming Liu has authored 3 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Pathology and Forensic Medicine and 2 papers in Immunology. Recurrent topics in Ta-Ming Liu's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Chronic Myeloid Leukemia Treatments (1 paper). Ta-Ming Liu is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Chronic Myeloid Leukemia Treatments (1 paper). Ta-Ming Liu collaborates with scholars based in United States. Ta-Ming Liu's co-authors include Amy J. Johnson, Leslie A. Andritsos, Arletta Lozanski, Joseph M. Flynn, Kami J. Maddocks, Jennifer A. Woyach, Jason A. Dubovsky, John C. Byrd, Ethan Strattan and Jeffrey A. Jones and has published in prestigious journals such as Blood.

In The Last Decade

Ta-Ming Liu

3 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ta-Ming Liu United States	3	121	95	51	32	30	3	135
Kelly A. Smucker United States	2	129 1.1×	83 0.9×	67 1.3×	38 1.2×	60 2.0×	2	159
Sean D. Reiff United States	7	135 1.1×	102 1.1×	32 0.6×	58 1.8×	45 1.5×	13	163
Anouk de Jong United States	5	99 0.8×	66 0.7×	26 0.5×	39 1.2×	29 1.0×	7	116
Maité Cabes United Kingdom	5	100 0.8×	96 1.0×	39 0.8×	18 0.6×	41 1.4×	10	139
Alexander Jethwa Germany	6	127 1.0×	82 0.9×	57 1.1×	22 0.7×	72 2.4×	8	183
Yiling Yu China	6	122 1.0×	117 1.2×	44 0.9×	47 1.5×	18 0.6×	8	152
Pauline Robbe United Kingdom	5	91 0.8×	88 0.9×	42 0.8×	15 0.5×	34 1.1×	14	137
Diego Cortese Sweden	2	81 0.7×	58 0.6×	37 0.7×	16 0.5×	24 0.8×	3	97
Annalisa D’Avola United Kingdom	8	91 0.8×	67 0.7×	69 1.4×	14 0.4×	65 2.2×	13	159
Jared Henderson United States	5	45 0.4×	52 0.5×	48 0.9×	20 0.6×	38 1.3×	14	131

Countries citing papers authored by Ta-Ming Liu

Since Specialization

Citations

This map shows the geographic impact of Ta-Ming Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ta-Ming Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ta-Ming Liu more than expected).

Fields of papers citing papers by Ta-Ming Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ta-Ming Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ta-Ming Liu. The network helps show where Ta-Ming Liu may publish in the future.

Co-authorship network of co-authors of Ta-Ming Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ta-Ming Liu. A scholar is included among the top collaborators of Ta-Ming Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ta-Ming Liu. Ta-Ming Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Liu, Ta-Ming, Jennifer A. Woyach, Yiming Zhong, et al.. (2015). Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation. Blood. 126(1). 61–68. 131 indexed citations

2.

Liu, Ta-Ming, et al.. (2014). A Breakthrough Therapy in Relapsed Chronic Lymphocytic Leukemia: the Combination of Idelalisib and Rituximab. 2 indexed citations

3.

Liu, Ta-Ming, Yonghua Ling, Mitch A. Phelps, et al.. (2013). OSU-T315, An Integrin-Linked Kinase (ILK) Inhibitor, Induces Apoptosis By Targeting B Cell Receptor and CD49d Mediated AKT/ERK Activation In Chronic Lymphocytic Leukemia Cells. Blood. 122(21). 2523–2523. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact